Most Recent
Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent.
ASIC has lost its challenge to findings that a revenue sharing arrangement between the Commonwealth Bank of Australia and former subsidiary Colonial First State Investments did not breach conflicted remuneration provisions of the Corporations Act.
After being hit by a $200 million claim in Australia, infant formula company Care A2 Plus is asking the court to block US business partner Gensco from filing a second lawsuit in its home country, which it says is intended to "harass and split the resources" of CAP and its directors.
Two class actions against Victorian aged care providers on behalf of families of residents who died due to alleged failures during the COVID-19 pandemic have appealed a ruling that rejected their bid for insurance and financial information to assist in mediation.
Cryptocurrency lender Helio Lending Pty has been slapped with a non-conviction bond for falsely claiming that it held an Australian credit license.
Deloitte has settled a shareholder class action over its audits of collapsed construction group Hastie, a case which dragged on for six years as the accounting firm unsuccessfully fought to shield its audit reports.
A class action against Carnival over norovirus outbreaks on its Sun Princess cruise ship has defeated the cruise operator’s second strike out bid, with a judge saying the failure to identify what exactly went wrong “may not be fatal” to the case.
Retailer Best & Less will back-pay staff over $5.2 million as part of an undertaking to the Fair Work Ombudsman, after an internal review found salaried managers were not paid enough to cover their entitlements.
A judge who previously described as a "schemozzle" a law firm's attempt to drop a class action over Telstra's COVID-19 vaccine policy has refused a bid to keep secret Clive Palmer's involvement as funder of the aborted litigation.
Australian infant formula company Care A2 Plus has hit back at a $200 million lawsuit by US business partner Gensco, arguing the distributor did not properly execute the agreement at the heart of the dispute as allegations of phantom companies fly.